BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 15671555)

  • 1. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M
    J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas.
    Kobayashi T; Masumoto J; Tada T; Nomiyama T; Hongo K; Nakayama J
    Clin Cancer Res; 2007 Jul; 13(13):3868-74. PubMed ID: 17606719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
    Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
    Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival.
    Warth A; Simon P; Capper D; Goeppert B; Tabatabai G; Herzog H; Dietz K; Stubenvoll F; Ajaaj R; Becker R; Weller M; Meyermann R; Wolburg H; Mittelbronn M
    J Neurosci Res; 2007 May; 85(6):1336-46. PubMed ID: 17335082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer.
    Anttila MA; Kellokoski JK; Moisio KI; Mitchell PJ; Saarikoski S; Syrjänen K; Kosma VM
    Br J Cancer; 2000 Jun; 82(12):1974-83. PubMed ID: 10864206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
    Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
    Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
    Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
    Gee JM; Robertson JF; Ellis IO; Nicholson RI; Hurst HC
    J Pathol; 1999 Dec; 189(4):514-20. PubMed ID: 10629551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
    Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of urokinase-type plasminogen activator in human gliomas.
    Hsu DW; Efird JT; Hedley-Whyte ET
    Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
    Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
    Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
    Stojic J; Hagemann C; Haas S; Herbold C; Kühnel S; Gerngras S; Roggendorf W; Roosen K; Vince GH
    Neurosci Res; 2008 Jan; 60(1):40-9. PubMed ID: 17980449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.